임상시험 트래커
추적 기업 30곳의 임상 6,982건 (국내 전체 이력 · 글로벌 진행 중). 출처: ClinicalTrials.gov
기업
29건 표시
- 1/2상모집 중단 (진행 중)· Influenza AA Phase I/II Study on Safety AND Immunogenicity of AZD4117 and AZD5315 Vaccines (PANDA)
리드: 아스트라제네카
- 1/2상모집 중단 (진행 중)· Refractory Systemic Lupus ErythematosusA Study of GC012F Injection in Subjects With Refractory Systemic Lupus Erythematosus
협력: 아스트라제네카
- 1/2상모집 중단 (진행 중)· Hepatocellular CarcinomaA Phase I/II Study to Evaluate AZD5851 in GPC3+ Advanced/Recurrent Hepatocellular Carcinoma
리드: 아스트라제네카
- 1/2상모집 중단 (진행 중)· Overweight and ObesityA Trial to Learn How Safe AZD9550 Monotherapy and Combined With AZD6234 is in People With or Without Type 2 Diabetes Who Are Living With Obesity and Overweight
리드: 아스트라제네카
- 1/2상모집 중단 (진행 중)· Carcinoma, Non-Small-Cell LungA Study of Dato-DXd in Chinese Patients With Advanced Non-Small Cell Lung Cancer, Triple-negative Breast Cancer and Other Solid Tumors (TROPION-PanTumor02)
리드: 아스트라제네카
- 1/2상모집 중단 (진행 중)· Metastatic Prostate CancerStudy of AZD5305 When Given in Combination With New Hormonal Agents in Patients With Metastatic Prostate Cancer
리드: 아스트라제네카
- 1/2상모집 중단 (진행 중)· Neurofibromatosis Type 1Pharmacokinetics, Safety and Efficacy of the Selumetinib Granule Formulation in Children Aged ≥1 to <7 Years With NF1-related Symptomatic, Inoperable PN
리드: 아스트라제네카 · 협력: 머크(MSD)
- 1/2상모집 중단 (진행 중)· Carcinoma, Non-Small-Cell LungA Study to Assess the Safety and Efficacy of AZD7789 in Participants With Advanced or Metastatic Solid Cancer
리드: 아스트라제네카
- 1/2상모집 중단 (진행 중)· Non-Small-Cell Lung CarcinomaA Study of AZD2936 Anti-TIGIT/Anti-PD-1 Bispecific Antibody in Participants With Advanced or Metastatic NSCLC
리드: 아스트라제네카
- 1/2상모집 중단 (진행 중)· Extensive Stage Lung Small Cell CarcinomaOlaparib and Durvalumab With Carboplatin, Etoposide, and/or Radiation Therapy for the Treatment of Extensive-Stage Small Cell Lung Cancer, PRIO Trial
협력: 아스트라제네카
- 1/2상모집 중단 (진행 중)· Metastatic Breast CancerA Phase 1b/2 Study of T-DXd Combinations in HER2-positive Metastatic Breast Cancer
리드: 아스트라제네카
- 1/2상모집 중단 (진행 중)· B-Cell Non-Hodgkin LymphomaAcalabrutinib and Anti-CD19 CAR T-cell Therapy for the Treatment of B-cell Lymphoma
협력: 아스트라제네카
- 1/2상모집 중단 (진행 중)· Idiopathic Pulmonary Fibrosis (IPF)Saracatinib in the Treatment of Idiopathic Pulmonary Fibrosis
협력: 아스트라제네카
- 1/2상모집 중단 (진행 중)· Ovarian CancerStudy of AZD5305 as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Malignancies
리드: 아스트라제네카
- 1/2상모집 중단 (진행 중)· Pancreatic AdenocarcinomaRadiation Therapy in Combination With Durvalumab for People With Pancreatic Cancer
협력: 아스트라제네카
- 1/2상모집 중단 (진행 중)· Phase I: Relapsed or Refractory B-cell MalignanciesStudy of Acalabrutinib in Chinese Adult Subjects With Relapsed or Refractory Mantle Cell Lymphoma, Chronic Lymphocytic Leukemia or Other B-cell Malignancies
리드: 아스트라제네카
- 1/2상모집 중단 (진행 중)· Triple Negative Breast CancerPaclitaxel + Carboplatin + Durvalumab With or Without Oleclumab for Previously Untreated Locally Recurrent Inoperable or Metastatic TNBC
협력: 아스트라제네카
- 1/2상모집 중단 (진행 중)· Triple Negative Breast NeoplasmsA Study of Novel Anti-cancer Agents in Patients With Metastatic Triple Negative Breast Cancer
리드: 아스트라제네카
- 1/2상모집 중단 (진행 중)· Oral Cavity Squamous Cell CarcinomaDurvalumab With or Without Tremelimumab in Resectable Locally Advanced Squamous Cell Carcinoma of the Oral Cavity
협력: 아스트라제네카
- 1/2상모집 중단 (진행 중)· Breast NeoplasmsWindow of Opportunity Trial of Neoadjuvant Olaparib and Durvalumab for Triple Negative or Low ER+ Breast Cancer
협력: 아스트라제네카
- 1/2상모집 중단 (진행 중)· Advanced Kidney CancerStudy of Durvalumab and Guadecitabine in Advanced Kidney Cancer
협력: 아스트라제네카
- 1/2상모집 중단 (진행 중)· Urothelial CarcinomaModern Immunotherapy in BCG-Unresponsive, BCG-Relapsing and High Risk BCG-Naive Non-Muscle Invasive Urothelial Carcinoma of the Bladder
협력: 아스트라제네카
- 1/2상모집 중단 (진행 중)· Non-Small Cell Lung CancerOsimertinib and Gefitinib in EGFR Inhibitor naïve Advanced EGFR Mutant Lung Cancer
협력: 아스트라제네카
- 1/2상모집 중단 (진행 중)· Esophageal AdenocarcinomaDurvalumab, an Anti-PDLI Antibody, and Tremelimumab, an Anti-CTLA4 Antibody, and Chemoradiation Before Surgery for Esophageal Cancer
협력: 아스트라제네카
- 1/2상모집 중단 (진행 중)· OvarianA Phase I/II Study of MEDI4736 in Combination With Olaparib in Patients With Advanced Solid Tumors.
리드: 아스트라제네카
- 1/2상모집 중단 (진행 중)· Non Hodgkin LymphomaStudy of Acalabrutinib Alone or in Combination Therapy in Subjects With B-cell Non-Hodgkin Lymphoma
협력: 아스트라제네카
- 1/2상모집 중단 (진행 중)· Estrogen Receptor Positive Breast CancerFulvestrant +/- Akt Inhibition in Advanced Aromatase Inhibitor Resistant Breast Cancer
협력: 아스트라제네카
BioPulse가 제공하는 정보는 공개된 자료를 요약·정리한 것으로, 투자 조언이나 의료 조언이 아닙니다. 임상 데이터·규제 일정·공시 내용은 반드시 원문을 직접 확인하시기 바랍니다.